Study details
Enrolling now
Acute Equol Supplementation and Vascular Function in Women With and Without CKD
University of Colorado, Denver
NCT IDNCT06128278ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
38
Study length
about 3.8 years
Ages
50–69
Sex
Female only
Locations
1 site in CO
What this study is about
Researchers are testing whether taking equol, a type of plant compound, improves vascular function in women with and without chronic kidney disease. The trial will measure how equol affects blood vessels after it's taken orally.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take S-equol
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Change in Carotid Femoral Pulse Wave Velocity
Body systems
Renal